About This 510(k) Submission
K161954 is an FDA 510(k) clearance for the Atellica Solution, Atellica A-LYTE Integrated Multisensor Na+/K+/CI-, Atellica CH Albumin BCP Reagent (Alb_p), Atellica IM Thyroid Stimulating Hormone TSH, Atellica CH Vancomycin (Vanc), a Electrode, Ion Specific, Sodium (Class II — Special Controls, product code JGS), submitted by Siemens Healthcare Diagnostics (New York, US). The FDA issued a Cleared decision on March 9, 2017, 234 days after receiving the submission on July 18, 2016. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1665.